Calidi Biotherapeutics In...

AMEX: CLDI · Real-Time Price · USD
5.28
0.24 (4.76%)
At close: Aug 15, 2025, 3:59 PM
5.24
-0.76%
After-hours: Aug 15, 2025, 07:55 PM EDT

Calidi Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 45K 449K
Cost of Revenue
1.53M 1.26M 274K 94K
Gross Profit
-1.53M -1.26M -229K 355K
Operating Income
-21.78M -28.99M -23.13M -10.48M
Interest Income
n/a n/a n/a n/a
Pretax Income
-22.2M -29.2M -25.42M -10.92M
Net Income
-22.14M -29.22M -25.43M -10.93M
Selling & General & Admin
12.9M 15.98M 15.64M 6.16M
Research & Development
8.88M 13.01M 7.26M 4.67M
Other Expenses
n/a -1.26M n/a n/a
Operating Expenses
21.78M 27.74M 22.9M 10.84M
Interest Expense
933K 3.75M 158K 614K
Selling & Marketing Expenses
n/a n/a -260K n/a
Cost & Expenses
-21.78M 28.99M 23.17M 10.93M
Income Tax Expense
14K 16K 11K 11K
Shares Outstanding (Basic)
664.41K 140.16K 70.59K 238.63K
Shares Outstanding (Diluted)
664.41K 140.16K 70.59K 238.63K
EPS (Basic)
-35.7 -207.61 -358.8 14.16
EPS (Diluted)
-35.7 -207.61 -358.8 14.16
EBITDA
-21.78M -24.2M -25M -9.45M
EBIT
-22.57M -25.45M -25.26M -9.61M
Depreciation & Amortization
791K 1.26M 260K 156K